Stem Cell Treatments
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
48
NCT05626712
Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes
Phase: Phase 1/2
Role: Lead Sponsor
Start: Apr 7, 2023
Completion: Jan 31, 2028
NCT06053242
Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain
Start: May 21, 2024
Completion: Oct 1, 2026
Loading map...